Centre for Advanced Research in Environmental Genomics, Department of Biology, University of Ottawa, Ottawa, Ontario K1N6N5, Canada.
Aquat Toxicol. 2010 Oct 1;100(1):128-37. doi: 10.1016/j.aquatox.2010.07.022. Epub 2010 Jul 23.
Fluoxetine (FLX) is one of the most commonly detected pharmaceuticals in wastewater and bioaccumulates in wild-caught fish, especially in brain, liver and muscle tissues. Previous studies indicated that FLX is pharmacologically active in fish species exerting anorexigenic effects, but it is not clear whether waterborne FLX has any potential effects on regulating food intake and energy metabolism. In this study, we investigated the effect of two doses of FLX, an environmental concentration of 540 ng/L, and 100-times this concentration (54 μg/L), on feeding and key metabolic parameters in goldfish. Fish were exposed for a period of 28 days and changes in food intake and body mass were assessed. Pair-fed groups were maintained to discern primary FLX-induced effects from secondary metabolic responses induced by the decreased food intake. Additionally, an untreated control group and a fasted group were used to further compare physiological changes in the context of nutritional status of the animals. Significant decreases in food intake and weight gain were recorded in goldfish exposed to 54 μg/L FLX. Furthermore a significant decrease occurred in circulating glucose levels in the group exposed to 540 ng/L FLX. To elucidate potential mechanisms, we investigated gene expression of feeding neuropeptides in the neuroendocrine brain of goldfish as well as gene expression and enzymatic activity of glycolytic and gluconeogenetic enzymes in liver and muscle tissues. The results confirm brain gene expression patterns in line with potential anorexigenic effects in the hypothalamus, with increased expression in corticotropin-releasing factor (CRF) and decreased expression of neuropeptide Y (NPY). With respect to glucose metabolism, liver gene expression of the gluconeogenic enzyme fructose-1,6-bisphosphatase decreased and muscle hexokinase activity increased in fish exposed to 540 ng/L FLX. Overall, this study demonstrated anorectic properties of FLX at a dose of 54 μg/L FLX and moderate but significant effects on glucose metabolism in goldfish exposed to 540 ng/L FLX. Future studies investigating the importance of these changes in fish are warranted.
氟西汀(FLX)是废水中最常检测到的药物之一,并且在野生捕获的鱼类中生物累积,特别是在脑、肝和肌肉组织中。先前的研究表明,FLX 在摄食行为抑制作用方面对鱼类具有药理活性,但尚不清楚水相中的 FLX 是否对调节摄食和能量代谢有任何潜在影响。在这项研究中,我们研究了两种剂量的 FLX(环境浓度为 540ng/L 和 100 倍于该浓度的 54μg/L)对金鱼摄食和关键代谢参数的影响。鱼暴露了 28 天,并评估了食物摄入量和体重的变化。维持配对喂养组以辨别 FLX 引起的主要作用与因食物摄入量减少引起的次要代谢反应。此外,还使用未处理的对照组和禁食组进一步比较了动物营养状况背景下的生理变化。暴露于 54μg/L FLX 的金鱼的食物摄入量和体重增加显著减少。此外,暴露于 540ng/L FLX 的金鱼的循环葡萄糖水平也显著降低。为了阐明潜在的机制,我们研究了金鱼神经内分泌脑中摄食神经肽的基因表达以及肝和肌肉组织中糖酵解和糖异生酶的基因表达和酶活性。结果证实了与下丘脑潜在厌食作用一致的脑基因表达模式,促肾上腺皮质释放因子(CRF)表达增加,神经肽 Y(NPY)表达减少。关于葡萄糖代谢,暴露于 540ng/L FLX 的鱼的肝脏中糖异生酶果糖-1,6-二磷酸酶的基因表达降低,肌肉己糖激酶活性增加。总的来说,这项研究表明,54μg/L FLX 剂量的 FLX 具有厌食作用,而 540ng/L FLX 暴露的金鱼的葡萄糖代谢也有适度但显著的影响。未来研究调查这些变化在鱼类中的重要性是必要的。